HOME >> MEDICINE >> NEWS
JRRD releases single-topic issue focused on vision rehabilitation

Migration and proliferation of retinal pigment epithelium on extracellular matrix ligands, pg. 713

Our goal is to develop a surgical treatment that will improve vision for patients with agerelated macular degeneration (AMD). AMD is the most common cause of blindness among people over age 55 in the United States (including veterans). In most AMD patients with severe visual loss, abnormal blood vessels grow under the central retina (the area that provides high resolution vision) and cause bleeding, scarring, and blindness. If surgical excision of the abnormal vessels can be combined with resurfacing of the dissection area by the patient's own retinal pigment epithelial cells (RPE), then vision might be restored postoperatively. We studied the ability of young versus old RPE cells to grow in cell culture on surfaces that contain proteins believed to foster RPE migration and proliferation. We found that old as well as young RPE cells can grow in cell culture on surfaces that contain appropriate extracellular matrix ligands. These results will guide us in developing techniques to provide sight-restoring treatment for patients with exudative AMD.

Status of the feline retina 5 years after subretinal implantation, pg. 723

The long-term biocompatibility and durability of retinal prosthetics are essential components of a viable clinical device. In this study, we report results obtained 5 years following implantation of normal adult cats with a subretinal microphotodiode array. All implants functioned throughout the study period. Small changes in retinal function and morphology were noted that could be attributed to surgical manipulation or the presence of a solid device in the subretinal space. No indications of rejection of the prosthesis existed. Clinical trials to determine whether visual improvements exist in patients implanted with subretinal devices of similar design are in progress, while animal studies address the mechanisms that m
'"/>

Contact: Dore Mobley
dore@vard.org
410-962-1800 x229
Journal of Rehabilitation Research
11-Jan-2007


Page: 1 2 3 4 5 6

Related medicine news :

1. NIAID releases MDR/XDR Tuberculosis research agenda
2. JRRD releases single-topic issue on pain and pain management
3. American College of Physicians releases new patient education resources
4. The AGA Institute releases report on the future of gastroenterology
5. Osteoarthritis initiative releases first data
6. ESC releases updated Guidelines for the Management of Stable Angina Pectoris
7. The ESC releases guidance document on Cardiac Rhythm Management product performance
8. Heart Rhythm Society releases draft recommendations on pacemakers, ICDs on April 26
9. ACP releases annual report on The State of the Nations Health Care
10. USP releases national report
11. CIHR releases research results to inform the development of benchmarks for wait times

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: JRRD releases single topic issue focused vision rehabilitation

(Date:6/18/2013)... 18, 2013 -- Lauren Sciences, a privately-held biotechnology ... platform technology, announced today that it was independently ... with its V-Smart Platform, and selected as a ... Group. , The report, " Early ... Emerging Companies ," features companies MCD Group independently ...
(Date:6/18/2013)... are more likely to keep their scheduled medical appointments ... feel their physician listens, explains things clearly and knows ... Johns Hopkins research suggests. , "If people feel their ... feel that doctor has their best interests at heart ... says study leader Tabor E. Flickinger, M.D., M.P.H., a ...
(Date:6/18/2013)... Obama officially declared June as Lesbian, Gay, ... despite advances in civil rights, sexual minority ... suicide than their heterosexual peers, according to ... of Missouri psychology graduate student recently published ... minority youth, which could help improve psychological ...
(Date:6/18/2013)... FDA to support the need for a blood test ... University of Rochester Medical Center just added significant evidence ... that it might be clinically useful to measure two ... M.P.H., an associate professor of Emergency Medicine at URMC, ... combination of two proteins released into the bloodstream after ...
(Date:6/18/2013)... penalties on hospitals with higher-than-expected rates of 30-day ... are evaluating the most accurate methods for tracking ... in the June issue of the Journal ... that the American College of Surgeons National Surgical ... accurate data tracking than another popular database, the ...
Breaking Medicine News(10 mins):Health News:Respect may be the key to stopping patient 'no shows' 2Health News:Sexual minority youth need specialized treatment from therapists 2Health News:ACS NSQIP® data is more accurate than administrative data for tracking 30-day hospital readmissions 2Health News:ACS NSQIP® data is more accurate than administrative data for tracking 30-day hospital readmissions 3Health News:ACS NSQIP® data is more accurate than administrative data for tracking 30-day hospital readmissions 4
(Date:6/18/2013)... 2013 New-generation electronic designs are focused ... lightweight. Simultaneously, circuitry is increasing the number of ... which it performs at. Connecting cables from the ... equipment, such as cameras or detectors, must be ... connectors include custom cable designs for high-quality signal ...
(Date:6/18/2013)... EMERYVILLE, Calif. , June 18, 2013 ... today from a Phase 2/3 clinical trial of ... statistically significant improvement in levodopa-induced dyskinesia (LID) as ... versus placebo in the Unified Dyskinesia Rating Scale ... amantadine intended for once-nightly administration that is being ...
(Date:6/18/2013)... 2013   Polymer Technology Systems, Inc. ... Group to integrate the CardioChek ® ... by health systems across the country. The CardioChek ... distributed through Hanson Medical Systems , offers ... LDL cholesterol, triglycerides, and glucose. (Logo: ...
Breaking Medicine Technology:Omnetics Circular Connectors Offer Both Micro and Nano Interconnects for Highly Portable Electronic Systems, Meeting the Needs of Designers Looking for Size Reduction Options and Cable Flexibility 2Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 2Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 3Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 4Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 5Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 6Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients 2Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients 3
Cached News: